Evidence from biomarkers and surrogate endpoints.
The use of physiological, anatomical, and other biological tests is commonplace in the practice of medicine. In neurology, objectively measured tests termed biomarkers (BMs) are playing an increasing role in diagnosis and management of disease, both in clinical practice and in experimental therapeutics. This article will discuss the various applications of BMs to the assessment of therapies for neurological diseases and will use examples from neurological diseases to elucidate the strengths and potential weaknesses of BMs. As the understanding of the pathophysiology of many neurological diseases has improved, new BMs have been developed, and efforts have been made to use these as proxies for clinical endpoints. A BM used in this manner is referred to as a surrogate endpoint (SE). There are many potential advantages and disadvantages of using SEs in the evaluation of new therapies, and these will be reviewed as well. Furthermore, the evidence required for the development of an SE and the nature of the evidence that can be derived from the use of BMs and SEs will be discussed.
Feigin
Andrew
A
Center for Neurosciences, North Shore-Long Island Jewish Research Institute, Manhasset, New York 11030, USA. asfeigin@aol.com
D000818:Animals; D015415:Biomarkers; D002493:Central Nervous System Diseases / Q000175:diagnosis*; D002986:Clinical Trials as Topic / Q000592:standards; D003937:Diagnosis, Differential; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D012107:Research Design / Q000592:standards*
D015415:Biomarkers
Neurobiol Aging. 1994 Mar-Apr;15(2):275-6
7838311
J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):496-8
7738566
Arch Neurol. 1995 Aug;52(8):749-53
7639626
Neurology. 1995 Nov;45(11):1995-2004
7501148
Acta Neurol Scand. 1995 Dec;92(6):468-71
8750112
Neurology. 1996 Dec;47(6 Suppl 3):S161-70
8959985
J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):625-7
8971113
Brain. 1997 Dec;120 ( Pt 12):2187-95
9448574
Aust Fam Physician. 1998 Jul;27(7):631-2
9679387
J Neural Transm Suppl. 1999;55:97-102
10335496
JAMA. 1999 Jul 21;282(3):254-60
10422994
Neuroimaging Clin N Am. 1999 Aug;9(3):423-38
10433636
Pacing Clin Electrophysiol. 1999 Jul;22(7):1082-4
10456638
JAMA. 1999 Aug 25;282(8):771-8
10463714
Zhonghua Yi Xue Za Zhi (Taipei). 1999 Sep;62(9):586-90
10502848
Eur J Nucl Med. 1999 Nov;26(11):1413-23
10552082
Arch Neurol. 2000 Feb;57(2):263-7
10681087
Neurobiol Dis. 2000 Aug;7(4):240-50
10964596
Curr Atheroscler Rep. 2000 Mar;2(2):92-6
11122730
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
11240971
Ann Neurol. 2001 Apr;49(4):545-6
11310639
J Nucl Med. 2001 Mar;42(3):408-13
11337515
Biol Signals Recept. 2001 May-Aug;10(3-4):224-53
11351130
J Neurol. 2001 Apr;248(4):271-8
11374090
Am J Manag Care. 2001 May;7(5 Suppl):S144-7
11383376
Ann Neurol. 2001 Jul;50(1):121-7
11456302
Neurology. 2001 Aug 14;57(3):397-404
11502903
Adv Neurol. 2001;86:115-24
11553968
Control Clin Trials. 2001 Oct;22(5):485-502
11578783
JAMA. 2001 Oct 3;286(13):1573-4
11585466
Neurology. 2001 Oct 9;57(7):1222-9
11591840
Folia Neuropathol. 2001;39(1):1-5
11678345
Neuropsychobiology. 2001;44(4):172-5
11702016
Neurology. 2001 Dec 11;57(11):2089-94
11739831
J Epidemiol Community Health. 2002 Feb;56 Suppl 1:i19-24
11815640
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):493-6
11828830
JAMA. 2002 Apr 3;287(13):1653-61
11926889
Neurology. 2002 Apr 23;58(8 Suppl 4):S23-31
11971123
Semin Roentgenol. 2002 Jul;37(3):212-8
12226900
J Neurosci Res. 2002 Nov 1;70(3):392-401
12391602
Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):669-76
12450242
Mov Disord. 2002 Nov;17(6):1265-70
12465066
Curr Med Chem. 2003 Mar;10(5):349-65
12570696
Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8
12666096
Neurology. 2003 Apr 22;60(8):1234-40
12707423
Neuropsychopharmacology. 2003 Jun;28(6):1182-5
12700687
Clin Pharmacol Ther. 2003 Jun;73(6):481-90
12811358
Ann Neurol. 2003 Jul;54(1):93-101
12838524
Cerebrovasc Dis. 2003;16(3):280-5
12865617
Brain Res Bull. 2003 Aug 15;61(3):243-53
12909294
Curr Neurol Neurosci Rep. 2003 Jul;3(4):314-20
12930701
Neurology. 2003 Sep 9;61(5):596-7
12963745
Mov Disord. 2003 Oct;18 Suppl 7:S63-70
14531048
J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1447; author reply 1447
14570850
Am J Clin Pathol. 2003 Nov;120(5):672-5
14608891
Stroke. 2003 Dec;34(12):2930-4
14615618
Eur Neurol. 2004;51(1):1-5
14631121
Med J Aust. 1981 Oct 31;2(9):460-5
6119604
J Neuroradiol. 1986;13(1):1-10
3746435
Am Surg. 1987 Feb;53(2):77-9
3813220
Stat Med. 1989 Apr;8(4):431-40
2727467
Arch Neurol. 1989 Oct;46(10):1052-60
2508608
Hosp Community Psychiatry. 1989 Dec;40(12):1310
2591894
Neurology. 1990 Sep;40(9):1337-9
2118239
N Engl J Med. 1991 Mar 21;324(12):781-8
1900101
Neurol Clin. 1992 May;10(2):341-59
1584178
Neurology. 1993 Dec;43(12 Suppl 6):S6-16
8264913
Q J Med. 1994 Feb;87(2):71-3
8153290
J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):278-84
8158173
Lancet. 1994 Jul 16;344(8916):189-90
7912778
Stat Med. 1994 Jul 15-30;13(13-14):1423-35; discussion 1437-40
7973222